Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker JBIO
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | Atlas Venture Fund XII, L.P. Shareholder | JBIO Jade Biosciences, Inc. | 28,977 | $303.7K | — | Jun 25, 2025 | — | Form 144 ↗ |
| Jun 25, 2025 | Atlas Venture Associates XII, L.P. Shareholder | JBIO Jade Biosciences, Inc. | 235 | $2,463 | — | Jun 25, 2025 | — | Form 144 ↗ |
| Jun 24, 2025 | Atlas Venture Fund XII, L.P. Shareholder | JBIO Jade Biosciences, Inc. | 16,132 | $159.2K | — | Jun 24, 2025 | — | Form 144 ↗ |
| Jun 24, 2025 | Atlas Venture Associates XII, L.P. Shareholder | JBIO Jade Biosciences, Inc. | 131 | $1,293 | — | Jun 24, 2025 | — | Form 144 ↗ |
| May 6, 2025 | Atlas Venture Associates XII, L.P. Shareholder | JBIO Jade Biosciences, Inc. | 48 | $552 | — | May 6, 2025 | — | Form 144 ↗ |
| May 6, 2025 | Atlas Venture Fund XII, L.P. Shareholder | JBIO Jade Biosciences, Inc. | 5,883 | $67.7K | — | May 6, 2025 | — | Form 144 ↗ |
| Jun 14, 2024 | Marinus Verwijs Officer | JBIO Jade Biosciences, Inc. | 10,600 | $265.0K | 10b5-1 | Jun 14, 2024 | — | Form 144 ↗ |
| Jun 13, 2024 | Hunter C Gillies Officer | JBIO Jade Biosciences, Inc. | 6,000 | $147.0K | 10b5-1 | Jun 13, 2024 | — | Form 144 ↗ |
| May 17, 2024 | Hunter C Gillies Officer | JBIO Jade Biosciences, Inc. | 4,000 | $84.3K | 10b5-1 | May 17, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Timothy Noyes Officer, Director | JBIO Jade Biosciences, Inc. | 10,000 | $215.8K | 10b5-1 | May 16, 2024 | — | Form 144 ↗ |
| May 2, 2024 | Verwijs Marinus Officer | JBIO Jade Biosciences, Inc. | 1,981 | $41.6K | — | May 2, 2024 | — | Form 144 ↗ |
| May 1, 2024 | Timothy Noyes Officer, Director | JBIO Jade Biosciences, Inc. | 11,357 | $230.9K | 10b5-1 | May 1, 2024 | — | Form 144 ↗ |
| Apr 17, 2024 | Benjamin T. Dake Officer | JBIO Jade Biosciences, Inc. | 6,853 | $161.9K | 10b5-1 | Apr 17, 2024 | — | Form 144 ↗ |
| Apr 17, 2024 | Hunter C Gillies Officer | JBIO Jade Biosciences, Inc. | 4,000 | $89.5K | 10b5-1 | Apr 17, 2024 | — | Form 144 ↗ |
| Apr 16, 2024 | Timothy Noyes Officer, Director | JBIO Jade Biosciences, Inc. | 10,000 | $247.0K | 10b5-1 | Apr 16, 2024 | — | Form 144 ↗ |
| Apr 9, 2024 | Atlas Venture Associates XII, L.P. Director | JBIO Jade Biosciences, Inc. | 11,882 | $314.6K | — | Apr 9, 2024 | — | Form 144 ↗ |
| Apr 1, 2024 | George A. Eldridge Officer | JBIO Jade Biosciences, Inc. | 37,400 | $1.1M | 10b5-1 | Apr 1, 2024 | — | Form 144 ↗ |
| Apr 1, 2024 | Timothy Noyes Officer, Director | JBIO Jade Biosciences, Inc. | 10,000 | $300.0K | 10b5-1 | Apr 1, 2024 | — | Form 144 ↗ |
| Apr 1, 2024 | Marinus Verwijs Officer | JBIO Jade Biosciences, Inc. | 5,300 | $154.7K | 10b5-1 | Apr 1, 2024 | — | Form 144 ↗ |
| Mar 28, 2024 | Hunter C Gillies Officer | JBIO Jade Biosciences, Inc. | 9,000 | $265.5K | 10b5-1 | Mar 28, 2024 | — | Form 144 ↗ |
| Mar 19, 2024 | Marinus Verwijs Officer | JBIO Jade Biosciences, Inc. | 5,300 | $138.2K | 10b5-1 | Mar 19, 2024 | — | Form 144 ↗ |
| Mar 18, 2024 | Benjamin T. Dake Officer | JBIO Jade Biosciences, Inc. | 56,410 | $1.5M | 10b5-1 | Mar 18, 2024 | — | Form 144 ↗ |
| Mar 18, 2024 | Hunter C Gillies Officer | JBIO Jade Biosciences, Inc. | 7,000 | $181.1K | 10b5-1 | Mar 18, 2024 | — | Form 144 ↗ |
| Mar 7, 2024 | George A. Eldridge Officer | JBIO Jade Biosciences, Inc. | 30,000 | $716.1K | 10b5-1 | Mar 7, 2024 | — | Form 144 ↗ |
| Mar 7, 2024 | Hunter C Gillies Officer | JBIO Jade Biosciences, Inc. | 8,975 | $219.9K | 10b5-1 | Mar 7, 2024 | — | Form 144 ↗ |
| Feb 23, 2024 | Hunter C Gillies Officer | JBIO Jade Biosciences, Inc. | 511 | $9,965 | — | Feb 23, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | Hunter C Gillies Officer | JBIO Jade Biosciences, Inc. | 3,489 | $70.6K | 10b5-1 | Feb 20, 2024 | — | Form 144 ↗ |
| Feb 5, 2024 | Ralph W Niven Officer | JBIO Jade Biosciences, Inc. | 4,600 | $80.2K | 10b5-1 | Feb 5, 2024 | — | Form 144 ↗ |
| Jan 17, 2024 | Hunter Gillies Officer | JBIO Jade Biosciences, Inc. | 4,000 | $78.0K | 10b5-1 | Jan 17, 2024 | — | Form 144 ↗ |
| Jan 5, 2024 | Ralph W Niven Officer | JBIO Jade Biosciences, Inc. | 4,600 | $88.1K | 10b5-1 | Jan 5, 2024 | — | Form 144 ↗ |
| Dec 27, 2023 | Hunter Gillies Officer | JBIO Jade Biosciences, Inc. | 125 | $3,063 | 10b5-1 | Dec 27, 2023 | — | Form 144 ↗ |
| Dec 20, 2023 | Hunter Gillies Officer | JBIO Jade Biosciences, Inc. | 4,000 | $78.0K | 10b5-1 | Dec 20, 2023 | — | Form 144 ↗ |
| Dec 14, 2023 | Hunter Gillies Officer | JBIO Jade Biosciences, Inc. | 9,897 | $193.0K | 10b5-1 | Dec 14, 2023 | — | Form 144 ↗ |
| Dec 5, 2023 | Ralph W Niven Officer | JBIO Jade Biosciences, Inc. | 4,600 | $75.0K | 10b5-1 | Dec 5, 2023 | — | Form 144 ↗ |
| Nov 22, 2023 | Benjamin T. Dake Officer | JBIO Jade Biosciences, Inc. | 37,172 | $539.0K | 10b5-1 | Nov 22, 2023 | — | Form 144 ↗ |
| Nov 22, 2023 | Ralph W Niven Officer | JBIO Jade Biosciences, Inc. | 13,800 | $207.0K | 10b5-1 | Nov 22, 2023 | — | Form 144 ↗ |
| Sep 6, 2023 | Benjamin T. Dake Officer | JBIO Jade Biosciences, Inc. | 10,283 | $156.2K | 10b5-1 | Sep 6, 2023 | — | Form 144 ↗ |
| Aug 7, 2023 | Benjamin T. Dake Officer | JBIO Jade Biosciences, Inc. | 10,283 | $168.1K | 10b5-1 | Aug 7, 2023 | — | Form 144 ↗ |
| Jul 28, 2023 | Timothy Noyes Officer, Director | JBIO Jade Biosciences, Inc. | 5,478 | $98.6K | 10b5-1 | Jul 28, 2023 | — | Form 144 ↗ |
| Jul 17, 2023 | Timothy Noyes Officer, Director | JBIO Jade Biosciences, Inc. | 4,522 | $81.9K | 10b5-1 | Jul 17, 2023 | — | Form 144 ↗ |
| Jul 6, 2023 | Benjamin T. Dake Officer | JBIO Jade Biosciences, Inc. | 10,283 | $175.0K | 10b5-1 | Jul 6, 2023 | — | Form 144 ↗ |
| Jul 5, 2023 | Ralph Niven Officer | JBIO Jade Biosciences, Inc. | 2,250 | $38.9K | 10b5-1 | Jul 5, 2023 | — | Form 144 ↗ |
| Jul 3, 2023 | Timothy Noyes Officer, Director | JBIO Jade Biosciences, Inc. | 10,000 | $180.0K | 10b5-1 | Jul 3, 2023 | — | Form 144 ↗ |
| Jun 6, 2023 | Benjamin T. Dake Officer | JBIO Jade Biosciences, Inc. | 10,283 | $163.8K | 10b5-1 | Jun 6, 2023 | — | Form 144 ↗ |
| Jun 5, 2023 | Ralph W Niven Officer | JBIO Jade Biosciences, Inc. | 2,250 | $36.6K | 10b5-1 | Jun 5, 2023 | — | Form 144 ↗ |
| May 19, 2023 | Hunter Gillies Officer | JBIO Jade Biosciences, Inc. | 65 | $1,268 | 10b5-1 | May 19, 2023 | — | Form 144 ↗ |
| May 17, 2023 | Hunter Gillies Officer | JBIO Jade Biosciences, Inc. | 1,090 | $21.4K | 10b5-1 | May 17, 2023 | — | Form 144 ↗ |
| May 8, 2023 | Benjamin T. Dake Officer | JBIO Jade Biosciences, Inc. | 10,284 | $226.4K | 10b5-1 | May 8, 2023 | — | Form 144 ↗ |
| May 5, 2023 | Ralph W Niven Officer | JBIO Jade Biosciences, Inc. | 2,250 | $47.0K | 10b5-1 | May 5, 2023 | — | Form 144 ↗ |
| May 2, 2023 | Timothy Noyes Officer, Director | JBIO Jade Biosciences, Inc. | 693 | $14.7K | 10b5-1 | May 2, 2023 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:36 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances